Compare MRLN & QTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MRLN | QTRX |
|---|---|---|
| Founded | 2018 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Laboratory Analytical Instruments |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 172.8M | 160.0M |
| IPO Year | 2024 | 2017 |
| Metric | MRLN | QTRX |
|---|---|---|
| Price | $1.36 | $3.21 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 3 |
| Target Price | ★ $8.58 | $3.00 |
| AVG Volume (30 Days) | ★ 3.3M | 876.5K |
| Earning Date | 11-15-2026 | 11-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $37,632,000.00 |
| Revenue This Year | $9.23 | $3.55 |
| Revenue Next Year | $153.29 | $10.02 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 64.52 |
| 52 Week Low | $1.39 | $2.15 |
| 52 Week High | $17.00 | $8.77 |
| Indicator | MRLN | QTRX |
|---|---|---|
| Relative Strength Index (RSI) | 25.23 | 49.72 |
| Support Level | N/A | $2.89 |
| Resistance Level | $3.45 | $3.25 |
| Average True Range (ATR) | 0.17 | 0.25 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 8.92 | 18.37 |
Merlin Inc develops software that fulfills the functions of a human pilot in self-flying aircraft to enable both reduced crew and unmanned flight. This technology is designed to be scalable and adaptable across different aircraft types for a growing range of aircraft platforms. The company's aircraft-agnostic, AI-powered software is purpose-built for military and civil programs, and is powering an expanding range of missions and aircraft, through hundreds of autonomous flights from test facilities across the globe. It operates as a single operating and reportable segment.
Quanterix Corp is a life sciences company accelerating biomarker breakthroughs from discovery to diagnostics using ultra-sensitive translational research and spatial biology instruments, consumables, and services. The company sells proprietary instruments and related consumables to research laboratories, contract research organizations (CROs), academic institutions, and bio-pharmaceutical companies, and provides contract research services and clinical laboratory testing services, including four Laboratory Developed Tests (LDTs), through its Accelerator Laboratory. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, and SP-X Imaging and Analysis System. Geographically, it operates in North America, EMEA, and the Asia Pacific.